Long-term impact of the COVID-19 pandemic on obsessive-compulsive disorder.
Autor: | Sharma LP; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka 560029, India., Balachander S; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka 560029, India. Electronic address: srinivasbalachander@gmail.com., Thatikonda NS; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka 560029, India., Ganesh UM; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka 560029, India; Department of Clinical Psychology, NIMHANS, Bengaluru, Karnataka, India., Kishore C; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka 560029, India., Bhattacharya M; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka 560029, India; Department of Clinical Psychology, NIMHANS, Bengaluru, Karnataka, India., Thamby A; Senior Psychiatry Registrar, The Royal Melbourne Hospital and Northwestern Mental Health, Melbourne, VIC, Australia., Ts J; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka 560029, India., Narayanaswamy JC; Consultant Psychiatrist, Goulburn Valley Health, Shepparton, VIC, Australia., Arumugham SS; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka 560029, India., Reddy YJ; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka 560029, India. |
---|---|
Jazyk: | angličtina |
Zdroj: | Psychiatry research [Psychiatry Res] 2024 Jan; Vol. 331, pp. 115625. Date of Electronic Publication: 2023 Nov 24. |
DOI: | 10.1016/j.psychres.2023.115625 |
Abstrakt: | There is limited data on the long-term effect of the COVID-19 pandemic on obsessive-compulsive disorder (OCD). We report on the course of a cohort of individuals with OCD followed-up over a period of one year during the first wave of the COVID-19 pandemic in India. A cohort of 240 individuals registered at a specialty OCD clinic was regularly followed-up using standardized rating tools at three months, six months, and one year into the onset of the COVID-19 pandemic in India. These were compared with clinical ratings recorded in a comparable historical cohort of 207 individuals with OCD, followed up during a non-pandemic year. The pandemic and non-pandemic (historical control) cohorts did not differ in illness severity and rate of relapse. It was found that COVID-19-related anxiety declined over time. Among those patients who were treatment responders prior to the pandemic, COVID-19-related anxiety and non-adherence to medication predicted a relapse of symptoms. Contrary to our expectations, the rate of relapse and illness trajectory in the pandemic cohort did not differ from the non-pandemic cohort, suggesting that the pandemic did not impact our largely medication-adherent cohort. Adherence to treatment seemed to have a protective effect during the pandemic. Competing Interests: Declaration of Competing Interest All the study authors declare that they have no conflicts of interests, pertaining to this study. (Copyright © 2023 Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |